| 000 | 01740 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515024708.0 | ||
| 264 | 0 | _c20061128 | |
| 008 | 200611s 0 0 eng d | ||
| 022 | _a0003-4967 | ||
| 024 | 7 |
_a10.1136/ard.2006.051540 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHeiberg, M S | |
| 245 | 0 | 0 |
_aAdalimumab and methotrexate is more effective than adalimumab alone in patients with established rheumatoid arthritis: results from a 6-month longitudinal, observational, multicentre study. _h[electronic resource] |
| 260 |
_bAnnals of the rheumatic diseases _cOct 2006 |
||
| 300 |
_a1379-83 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdalimumab |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadverse effects |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xadverse effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aRødevand, E | |
| 700 | 1 | _aMikkelsen, K | |
| 700 | 1 | _aKaufmann, C | |
| 700 | 1 | _aDidriksen, A | |
| 700 | 1 | _aMowinckel, P | |
| 700 | 1 | _aKvien, T K | |
| 773 | 0 |
_tAnnals of the rheumatic diseases _gvol. 65 _gno. 10 _gp. 1379-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/ard.2006.051540 _zAvailable from publisher's website |
| 999 |
_c16280425 _d16280425 |
||